Indian Medtech Firms Shift Focus to Exports Amid MNC Dominance in Domestic Market
Indian medtech companies are increasingly turning to international markets as established multinational corporations (MNCs) maintain a stronghold in the domestic sector. Despite robust growth in India’s healthcare infrastructure, local firms often struggle to compete with the scale, brand recognition, and advanced technologies of global players.
In response, Indian medtech firms are leveraging their cost-effective manufacturing capabilities and innovative solutions to tap into export opportunities. Markets in Southeast Asia, Africa, and the Middle East are emerging as key destinations, offering less saturated competition and significant demand for affordable medical devices.
The Indian government’s Production Linked Incentive (PLI) schemes and export incentives have further boosted this transition. Experts believe this strategy not only diversifies revenue streams for Indian firms but also enhances the country's reputation as a global hub for medical technology.
While MNCs continue to dominate India’s high-end medtech segment, the export focus could pave the way for Indian firms to achieve greater global competitiveness.
Source: Mint
#healthcarestartup #startupfunding #dseide
Indian medtech companies are increasingly turning to international markets as established multinational corporations (MNCs) maintain a stronghold in the domestic sector. Despite robust growth in India’s healthcare infrastructure, local firms often struggle to compete with the scale, brand recognition, and advanced technologies of global players.
In response, Indian medtech firms are leveraging their cost-effective manufacturing capabilities and innovative solutions to tap into export opportunities. Markets in Southeast Asia, Africa, and the Middle East are emerging as key destinations, offering less saturated competition and significant demand for affordable medical devices.
The Indian government’s Production Linked Incentive (PLI) schemes and export incentives have further boosted this transition. Experts believe this strategy not only diversifies revenue streams for Indian firms but also enhances the country's reputation as a global hub for medical technology.
While MNCs continue to dominate India’s high-end medtech segment, the export focus could pave the way for Indian firms to achieve greater global competitiveness.
Source: Mint
#healthcarestartup #startupfunding #dseide
Indian Medtech Firms Shift Focus to Exports Amid MNC Dominance in Domestic Market
Indian medtech companies are increasingly turning to international markets as established multinational corporations (MNCs) maintain a stronghold in the domestic sector. Despite robust growth in India’s healthcare infrastructure, local firms often struggle to compete with the scale, brand recognition, and advanced technologies of global players.
In response, Indian medtech firms are leveraging their cost-effective manufacturing capabilities and innovative solutions to tap into export opportunities. Markets in Southeast Asia, Africa, and the Middle East are emerging as key destinations, offering less saturated competition and significant demand for affordable medical devices.
The Indian government’s Production Linked Incentive (PLI) schemes and export incentives have further boosted this transition. Experts believe this strategy not only diversifies revenue streams for Indian firms but also enhances the country's reputation as a global hub for medical technology.
While MNCs continue to dominate India’s high-end medtech segment, the export focus could pave the way for Indian firms to achieve greater global competitiveness.
Source: Mint
#healthcarestartup #startupfunding #dseide
